Ethnic disparities are apparent for incidence, mortality and survival of blood cancers, according to a study of the New Zealand Cancer Registry (2007 2019) and national mortality records. Blood cancers in 2653 Māori and 20,458 Europeans were identified. Incidence and mortality rates for leukaemia and myeloma were higher in Māori than Europeans. Cancer-specific survival outcomes were poorer for Māori vs Europeans across most blood cancer types, with age- and sex-adjusted hazard ratios of 1.77 (95% CI 1.57-2.00) for leukaemia, 1.18 (95% CI 0.65-2.16) for Hodgkin lymphoma,1.71 (95% CI 1.50-1.95) for non-Hodgkin lymphoma and 1.40 (95% CI 1.19-1.64) for myeloma.